The pharmaceutical landscape for glucose is evolving, and transdermal GLP-1 delivery systems represent a promising advance. Unlike injections, this method offers a less invasive way to deliver GLP-1 drugs. These https://barbararzet419437.targetblogs.com/41290188/glp-1-patches-a-novel-approach-to-diabetes-management